AI Day1 LLC
Access Industries Holdings LLC
ACCESS INDUSTRIES MANAGEMENT LLC
Blavatnik Len
10% Owner | 2024-08-05 17:05:27 | 12,929,322
0 | 12,929,322 | Form 13D |
Atlas Venture Opportunity Fund II L.P.
Atlas Venture Fund XI L.P.
Atlas Venture Associates XI L.P.
Atlas Venture Associates XI LLC
Atlas Venture Opportunity Fund I L.P.
Atlas Venture Associates Opportunity I L.P.
Atlas Venture Associates Opportunity I LLC
10% Owner | 2024-11-14 16:30:11 | 4,869,681
0 | 4,869,681 | Form 13G |
Atlas Venture Fund XI L.P.
10% Owner | 2024-11-14 16:30:11 | 4,869,681
0 | 4,869,681 | Form 13G |
Atlas Venture Fund XI L.P.
Atlas Venture Opportunity Fund I L.P.
ATLAS VENTURE ASSOCIATES X L.P.
Atlas Venture Associates X LLC
Atlas Venture Associates Opportunity I LLC
Atlas Venture Associates Opportunity I L.P.
10% Owner | 2024-11-14 16:30:11 | 4,869,681
0 | 4,869,681 | Form 13G |
Grant Julie Papanek
Director | 2023-03-03 17:48:33 | 0
2,880,761 | 2,880,761 | Form 4 |
Canaan XI L.P.
Canaan Partners XI LLC
10% Owner | 2022-11-02 16:15:55 | 2,548,403
0 | 2,548,403 | Form 13D |
Blackman Samuel C.
HEAD OF R&D | 2024-11-19 16:34:06 | 1,153,027
1,000,000 | 2,153,027 | Form 4 |
Bender Jeremy
CHIEF EXECUTIVE OFFICER | 2024-11-19 16:36:19 | 300,885
1,608,838 | 1,909,723 | Form 4 |
Atlas Venture Opportunity Fund I L.P.
10% Owner | 2022-07-06 16:42:35 | 991,396
0 | 991,396 | Form 4 |
York Charles N II
COO, CFO AND SECRETARY | 2024-11-19 16:30:20 | 343,133
0 | 343,133 | Form 4 |
Dubow Adam
GENERAL COUNSEL | 2024-11-19 16:32:07 | 114,116
0 | 114,116 | Form 4 |
Ramasastry Saira
Director | 2024-06-21 19:17:18 | 40,485
0 | 40,485 | Form 4 |
Becker Daniel J.
Director | 2023-06-26 19:15:02 | 37,500
0 | 37,500 | Form 4 |
Nicholson Garry A
Director | 2024-05-28 18:27:04 | 32,335
0 | 32,335 | Form 4 |
Gladstone Michael
Director | 2024-05-28 18:17:45 | 32,335
0 | 32,335 | Form 4 |
Josey John A.
Director | 2024-05-28 18:24:17 | 32,335
0 | 32,335 | Form 4 |
Grossman William
Director | 2024-05-28 18:44:36 | 32,335
0 | 32,335 | Form 4 |
Dable Habib J
Director | 2024-05-28 18:13:59 | 32,335
0 | 32,335 | Form 4 |
Holles Natalie C.
Director | 2024-05-28 18:21:04 | 32,335
0 | 32,335 | Form 4 |
Garland J. Scott
Director | 2024-05-28 18:48:07 | 32,335
0 | 32,335 | Form 4 |
TAKEDA PHARMACEUTICAL CO LTD
Takeda Pharmaceuticals U.S.A. Inc.
MILLENNIUM PHARMACEUTICALS INC
Takeda Ventures Inc.
10% Owner | 2023-02-03 17:06:04 | 0
0 | 0 | Form 13G |